Samuel Hazen N.'s most recent trade in HCA Healthcare Inc was a trade of 54,934 Common Stock done . Disclosure was reported to the exchange on Feb. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 54,934 | 86,165 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 502.05 per share. | 10 Feb 2026 | 21,323 | 64,842 (0%) | 0% | 502.0 | 10,705,212 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 502.95 per share. | 03 Feb 2026 | 14,716 | 60,437 (0%) | 0% | 502.9 | 7,401,386 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 500.69 per share. | 03 Feb 2026 | 7,395 | 48,040 (0%) | 0% | 500.7 | 3,702,626 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 500.02 per share. | 03 Feb 2026 | 6,189 | 41,851 (0%) | 0% | 500.0 | 3,094,609 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 498.80 per share. | 03 Feb 2026 | 5,162 | 36,689 (0%) | 0% | 498.8 | 2,574,794 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 502.15 per share. | 03 Feb 2026 | 5,002 | 55,435 (0%) | 0% | 502.2 | 2,511,757 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 498.12 per share. | 03 Feb 2026 | 4,293 | 32,396 (0%) | 0% | 498.1 | 2,138,442 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Other type of transaction at price $ 498.35 per share. | 03 Feb 2026 | 1,045 | 31,231 (0%) | 0% | 498.4 | 520,776 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Other type of transaction at price $ 498.35 per share. | 03 Feb 2026 | 1,045 | 16,024 (0%) | 0% | 498.4 | 520,776 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 497.18 per share. | 03 Feb 2026 | 120 | 32,276 (0%) | 0% | 497.2 | 59,661 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2026 | 84,360 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 81.96 per share. | 29 Jan 2026 | 84,360 | 116,636 (0%) | 0% | 82.0 | 6,914,146 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 55,846 | 55,846 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 488.27 per share. | 29 Jan 2026 | 41,483 | 75,153 (0%) | 0% | 488.3 | 20,254,904 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2025 | 14,830 | 32,276 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 69.58 per share. | 31 Oct 2025 | 58,050 | 75,279 (0%) | 0% | 69.6 | 4,039,119 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 58,050 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 459.68 per share. | 31 Oct 2025 | 28,173 | 47,106 (0%) | 0% | 459.7 | 12,950,565 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2025 | 90,076 | 0 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 13 May 2025 | 90,076 | 93,088 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 13,218 | 76,418 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 321.92 per share. | 13 Feb 2025 | 4,742 | 71,676 (0%) | 0% | 321.9 | 1,526,545 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 74,620 | 74,620 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 16,731 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 12,084 | 66,212 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 78,296 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 14,979 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 0 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 7,115 | 7,115 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 3,012 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2024 | 3,012 | 63,200 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | N. Hazen Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 78,440 | 296,131 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel Hazen N. | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 308.55 per share. | 16 Feb 2024 | 30,387 | 265,744 (0%) | 0% | 308.6 | 9,375,909 | Common Stock |
| HCA Healthcare | Hazen N. Samuel | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 79,784 | 79,784 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 155,923 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 7,864 | 7,864 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 4,647 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 4,647 | 151,276 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 94,880 | 200,557 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 262.84 per share. | 17 Feb 2023 | 36,770 | 163,787 (0%) | 0% | 262.8 | 9,664,627 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.96 per share. | 03 Feb 2023 | 59,000 | 137,885 (0%) | 0% | 69.0 | 4,068,640 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2023 | 59,000 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.08 per share. | 03 Feb 2023 | 32,208 | 105,677 (0%) | 0% | 258.1 | 8,312,241 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jan 2023 | 82,880 | 82,880 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 85,040 | 408,704 (0%) | 0% | 0 | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.10 per share. | 18 Feb 2022 | 35,830 | 378,885 (0%) | 0% | 244.1 | 8,746,103 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 414,715 (0%) | 0% | - | Common Stock | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 6,011 | 0 | - | - | Restricted Stock Units | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 86,630 | 86,630 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.97 per share. | 29 Oct 2021 | 152,625 | 451,454 (0%) | 0% | 48.0 | 7,321,421 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 82,500 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 250.46 per share. | 29 Oct 2021 | 77,790 | 373,664 (0%) | 0% | 250.5 | 19,483,283 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Oct 2021 | 70,125 | 0 | - | - | Stock Appreciation Right | |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 251.84 per share. | 29 Oct 2021 | 38,260 | 326,823 (0%) | 0% | 251.8 | 9,635,230 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 250.96 per share. | 29 Oct 2021 | 8,581 | 365,083 (0%) | 0% | 251.0 | 2,153,528 | Common Stock |
| HCA Healthcare | Samuel N. Hazen | Director, CEO | Sale of securities on an exchange or to another person at price $ 252.44 per share. | 29 Oct 2021 | 3,159 | 323,664 (0%) | 0% | 252.4 | 797,465 | Common Stock |